7. Antibiotic envelope for cardiac implantable device infection prevention
Cardiac electronic devices are implanted in 1.5 million patients per year, according to the Cleveland Clinic. Infection is a risk when receiving the implant, which could lead to life-threatening complications.
Antibiotic-embedded envelopes are designed to encase the cardiac device and prevent infection.
“It’s not one-time risk. It’s a lifetime risk,” Dr. Khaldoun Tarakji, a staff member in cardiovascular medicine at the Cleveland Clinic, said. “Patients are outliving their devices.”